January 9, 2025 - 02:56

China has concluded a significant three-day anti-corruption conference, emphasizing its commitment to intensifying efforts against graft in various sectors, particularly finance, energy, and sports. This initiative represents a crucial aspect of the government’s broader strategy to combat corruption, which has been a persistent issue within the country.
State media has taken a leading role in promoting this campaign, with CCTV airing a documentary series that highlights the importance of transparency and accountability in public service. The conference underscored the necessity of rigorous oversight and the enforcement of strict regulations to ensure that corrupt practices are identified and addressed swiftly.
Officials have indicated that the anti-corruption drive will not only focus on high-profile cases but will also seek to instill a culture of integrity across all levels of government and industry. As China continues to navigate its economic landscape, the emphasis on eradicating corruption is expected to play a pivotal role in fostering public trust and maintaining stability.
May 14, 2026 - 00:55
Aeluma Announces Third Quarter Fiscal 2026 Financial ResultsAeluma, Inc., a company specializing in compound semiconductor technologies, has released its financial results for the third quarter of fiscal year 2026. The report comes alongside several major...
May 13, 2026 - 11:31
MCK Q1 Deep Dive: Revenue Misses Analyst Expectations as Margin Initiatives ContinueHealthcare distributor McKesson reported first-quarter earnings that missed revenue expectations, though the company continued to push ahead with margin-focused initiatives. For the quarter ending...
May 12, 2026 - 23:07
Prudential Financial Declares Quarterly Dividend on Common StockNEWARK, N.J., May 12, 2026 -- Prudential Financial, Inc. has declared a quarterly dividend of $1.40 per share on its common stock. The payment is scheduled for June 11, 2026, and will go to...
May 12, 2026 - 03:06
Cellectis Reports First Quarter 2026 Financial ResultsCellectis has announced its financial results for the first quarter of 2026, alongside updates on its clinical pipeline and preclinical research programs. The company is advancing its pivotal...